These 15 changes will appear in drugstores in 2020
1. The supervision of drugstores is more and more strict, and the inspection is normalized. Since December 1, the new version of drug administration law has been officially implemented. On the one hand, the supervision and inspection efforts have been further strengthened, and the illegal acts have been punished to people. According to the new drug administration law, even if only one box of fake drugs is sold, a minimum fine of 15 times (100000 if less than 100000), i.e. at least 1.5 million, shall be imposed. On the other hand, GSP certification was completely cancelled, accompanied by dynamic supervision and inspection normalization. According to the latest version of measures for the supervision and administration of drug distribution, even if it is not illegal, retail pharmacies should be inspected at least once every three years, which means that nearly 160000 pharmacies should be inspected at least every year. In addition, the frequency of inspection will be increased for pharmacies that once had illegal behaviors and sold special drugs.
2. Full implementation of long-distance pharmacy: after March 15 of this year, the country strictly inspected the illegal behaviors such as the absence of licensed pharmacists and the "registration". In order to make the smooth transition of retail pharmacies, the "forgotten" long-distance pharmacy was proposed again. Up to now, 14 provinces and cities, including Sichuan, Henan, Anhui, Hubei, Shandong, Xinjiang, Jiangxi, Fujian, Shaanxi, Guizhou, Chongqing, Hebei, Heilongjiang, Hunan, have issued relevant documents this year, taking telemedicine as an effective supplement for licensed pharmacists of retail pharmacies. With the encouragement and support of provinces and cities, telemedicine will be fully implemented in 2020.
3. The retail drug price should be reduced - with the expansion of national centralized purchase, up to now, more than 8200 stores, such as ordinary people, Yikang medicine, and shuyumin, have implemented the national bid winning price, and the retail price of 25 drugs is the bid winning price. Moreover, a new batch of purchased varieties with volume has been determined, involving 35 varieties such as acarbose, Azithromycin, Metformin and metronidazole. According to the requirements of the state, and so on, in the future, there will be more drugs with lower prices. At the same time, the official website of Shanghai Pharmaceutical purchase website also released the notice of price negotiation for "drugs limited to pharmacies" this year, and required that all drugs sold in the designated pharmacies (medical insurance counters) for medical insurance should be priced by the designated pharmacies for medical insurance and drug manufacturers themselves. This also marks the beginning of drug price reduction negotiations in drugstores. It is understood that the first batch of "pharmacy limited drugs" has 701, involving amoxicillin, azithromycin, Omeprazole, Banlangen, clarithromycin and many other pharmacies often sell drugs. It's worth noting that according to Shanghai medical purchase network, this is only the first batch, and so on. Next, the second batch and the third batch are not far away.
4. The expansion of drugstores: there are two signs of the expansion of drugstores: first, the common people, Yikang medicine, shuyumin and so on follow up the national collection; second, up to now, Shandong, Zhejiang, Shanghai, Guangdong, Jiangsu and other provinces have incorporated retail drugstores into the collection platform.
5. The long-term prescription mode is spreading out - in October this year, the guidance on improving the drug use guarantee mechanism of urban and rural residents in the outpatient department of hypertension and diabetes issued by the state health insurance bureau, "improving the long-term prescription system of drugs used in the outpatient department of hypertension and diabetes, ensuring the patients' drug use needs, but avoiding repeated prescriptions." This is not the first time that the National Bureau has proposed. As early as April and November 2018, the national health and Health Commission issued two documents requiring relevant departments to explore and formulate standards and norms for chronic long-term prescriptions. In addition, many provincial drug administrations also issued relevant documents to link up the long-term prescription policy, explore the long-term prescription management mechanism of retail pharmacies, and said that for chronic patients who take prescription drugs stably for a long time, the prescription is only used once, and the pharmacies can sell drugs for a long time. Up to now, dozens of provinces and cities such as Shaanxi, Xinjiang, Anhui and Guizhou have released relevant documents.
6. A large number of non drugstores distribute and sell drugs - in August this year, the opinions on accelerating the development of circulation and promoting commercial consumption issued by the general office of the State Council clearly pointed out that we should promote the innovative development of circulation and optimize the consumption environment. Among them, Article 4 of the opinion "speeding up the development of chain convenience stores" clearly points out that "the pilot of simplifying the operation and approval procedures of tobacco and class B over-the-counter drugs shall be carried out." This also laid a foundation for the sale of drugs in convenience stores nationwide. After that, Jiangxi Province clearly issued a document to start the pilot chain supermarket sale of class B over-the-counter drugs. At the same time, Shandong, Sichuan, Zhejiang Jinhua and other places have released the approval of class B OTC business enterprises, which will further accelerate the distribution and sale of non drug retail enterprises.
7. Professional pharmacies are spreading out - judging from the semi annual report information of 2019 published by major listed chains, Dalian locks are transforming, and the specialization of pharmacy industry is overwhelming. Among them, there are more than one thousand specialized pharmacies of Sinopharm, with a revenue of more than 2 billion; 166 specialized pharmacies of Dexin, a subsidiary of China Resources, with a revenue of 3.1 billion; Jiuzhoutong plans to build another 10 billion listed specialized pharmacies; the four listed pharmacies take the construction of specialized pharmacies as the next strategic layout

8. The merger and acquisition of drugstore circle accelerated - at the end of this year, capital began to be active again in drugstore circle. In recent years, Guoda drugstore, common people, dashanlin, Yifeng drugstore, etc. have launched dozens of big acquisitions involving hundreds of stores. Among them, Guoda pharmacy is the craziest. In recent two months, it has launched three major mergers and Acquisitions: the first time it spent nearly 934 million yuan, taking over guokongtian and 438 stores; the second time it spent nearly 163 million yuan, taking over 75 stores of YANGHETANG; the third time it spent nearly 90 million yuan, taking over 96 stores of Ji'an Tang.
9. Internet drug sales need to be popular - as the new version of the drug administration law was officially implemented at the beginning of this month, it provides the possibility for online sales of prescription drugs, which also pushes Internet medicine to the "tuyere". With the layout of many enterprises, the era of medicine e-commerce has come completely. The new version of the drug administration law makes it clear that "drug marketing license holders and drug distributors shall abide by the relevant provisions of this Law in drug marketing when selling drugs through the Internet." But not as mentioned in the draft submitted for approval, "drug listing permit holders and drug dealers shall not sell prescription drugs directly through the third party platform through drug network". It can be seen that the state has adopted a "prudent and inclusive" attitude, which is not a one size fits all approach, but also gives more development opportunities to pharmaceutical e-commerce enterprises.
10. Difference in the allocation of licensed pharmacists - on October 16 this year, the State Food and Drug Administration replied to the questions mentioned by Internet users, such as "it is too difficult to recruit licensed pharmacists, and it is suggested to relax or adjust relevant policies". To adjust the policy of licensed pharmacists' allocation, CFDA made clear that "further explore and improve the policy of differentiated allocation of licensed pharmacists in combination with the actual situation." In addition, the provisions of "must have licensed pharmacists or other legally qualified pharmaceutical technicians" in the latest version of the "measures for the supervision and administration of drug trade" have been changed, which also makes it possible for provinces and cities to allocate licensed pharmacists in a differentiated way. On the premise of full drug safety, each province may formulate provisions for the allocation that meet the development of its own province and implement the practice of licensed pharmacists Pharmacists are equipped differently.
11. Accelerated classified management of drugstores - it was originally thought that the Ministry of Commerce would issue classified management measures for national retail drugstores at the beginning of this year, but it has been delayed until now. However, judging from the recent documents issued by each province, the measures for national retail drugstores are also coming. So far, Guangdong Province and Shandong Province have issued documents, and Sichuan and Yunnan Province have also issued documents Implementation of responsibilities.
12. Special drugs should be under special management - the latest version of the measures for the supervision and administration of drug distribution points out that the implementation of drug quality management standards for the trading enterprises of narcotic drugs, class I psychotropic drugs and drug precursor chemicals should be supervised and inspected at least twice a year; the implementation of drug distribution for vaccine distribution enterprises, class II psychotropic drugs and toxic drugs for medical use should be supervised and inspected at least twice a year The quality management specifications shall be supervised and inspected at least once a year.
13. Medical insurance drugstores began to classify - in order to ensure the implementation of new policies for the use of drugs for chronic disease patients and prevent designated drugstores from stealing medical insurance cards, on the basis of ordinary medical insurance drugstores, the number of designated retail drugstores for chronic disease patients of medical insurance was further expanded. Up to now, Hubei Wuhan, Xinjiang Urumqi, Yunnan Kunming have also issued relevant notices to start the pilot. From the perspective of the three pilot areas, the future medical insurance drugstores will be divided into two categories: one is the designated drugstore of chronic disease medical insurance, which can prohibit the sale of non drugs and enjoy the outflow bonus of chronic disease prescription; the other is the designated drugstore of general medical insurance, which can place and sell non drugs but prohibit the brushing of health care products.
14. Prohibition of health care products on medical insurance card - on August 1 this year, the State Health Insurance Bureau replied to the proposal of "broadening and liberating the scope of use of personal account of medical insurance card" put forward by the representatives of Qiu Bingyu and tuoqingming. The reply clearly pointed out that as a part of the basic medical insurance fund, the individual account can only be used to pay for the medical expenses incurred in the designated medical institutions or designated retail pharmacies, which meet the requirements of the basic medical insurance drug catalog, the scope of diagnosis and treatment projects, and the standard of medical service facilities, and is prohibited to be used for other consumption expenses other than medical insurance. This also means that, according to the regulations, the money in the personal account of medical insurance card can only be used for medical expenses within the scope of basic medical insurance projects, and the use of personal account of medical insurance card to brush non-medical products such as health care products and nutrition products is completely out of the question. At the same time, from the action of the provincial medical insurance bureaus, it is inevitable that the medical insurance card personal account is prohibited to brush health care products. Up to now, Guangdong and Guizhou medical insurance bureaus have made clear statements.
15. Drugstores are opening faster and faster - on November 29 this year, the "pilot implementation plan for full coverage of the reform of" separation of licenses "in the pilot free trade zone" issued by the State Food and drug administration clearly pointed out that since December 1, 2019, in Shanghai, Guangdong, Tianjin, Fujian, Liaoning, Zhejiang, Henan, Hubei, Chongqing, Sichuan, Shaanxi, Hainan, Shandong, Jiangsu In Guangxi, Hebei, Yunnan, Heilongjiang and other pilot free trade zones, the reform of business license related matters in the field of drug supervision was carried out in accordance with the implementation of notification commitment and optimization of approval services. On December 5, Kunming issued the first pharmaceutical business license of "notification and commitment system" drug store version, which lasted less than one hour from the submission of materials to the receipt of the license. This also standardizes the opening of drugstores, and new progress has been made in the examination and approval. According to the national requirements, the retail pharmacies in 18 pilot free trade zones such as Shanghai and Guangdong will be gradually implemented next year, which also means that the opening of pharmacies will be faster and faster in the future.
Looking for chemical products? Let suppliers reach out to you!
2026-07-02
-
Life Sciences Industry Overview
The coverage spans the global life sciences industry across pharmaceuticals and food & nutrition, tracking the shift from lowest-cost sourcing to supply continuity, quality, and risk management, along with product trends and the growing edge of differentiated, globally capable players.Published in: June.2026
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
The pharmaceutical industry will undergo four major changes
-
Significant changes in the industrial coatings market outlook
-
Four major changes on drug registration management measures
-
Pfizer Lifts 2025 Profit Forecast After Q2 Earnings Beat Sales Hit $14.65 Billion Shares Jump 2.8 Percent
-
Sandoz Set to Slash Canadian Weight-loss Drug Prices by Up to 70 Percent Generics Could Expand Patient Access
-
Syndax Q2 Net Loss Widens to $71.8 Million Despite 43 Percent Revenue Surge and New Drug Momentum
-
Vertex Shares Plunge 14.4 Percent After Pain Drug Trial Misses Key Target and Study Halt
-
Moderna to Cut 10 Percent of Staff as COVID Vaccine Sales Plunge Stock Drops 4 Percent
-
Trump Pressures 17 Pharma CEOs to Match US Drug Prices with Global Lows September 29 Deadline Set
-
Bayer Sets Aside $1.37 Billion for Roundup Lawsuits Raises 2025 Sales Forecast to €48 Billion
Recommend Reading
-
Mounjaro Reduces Heart Events by 8 Percent More Than Trulicity in 13,000-Patient Diabetes Trial
-
JB Pharma Q1 Net Profit Surges 14 Percent to ₹202 Crore Revenue Hits ₹1094 Crore with 30 Percent EBITDA Margin
-
Sun Pharma Halts US Expansion Amid 25 Percent Tariff Threat Net Profit Drops 20 Percent
-
FDA Orders Removal of “Suicidality Warning”: Are Weight-Loss Blockbusters Finally Cleared—or Is Regulators Giving the Market a Reality Check?
-
Pharma’s Tightrope in 2026: Safety, Competition and the Future of Obesity Treatment Innovation
-
China’s PE, PP and PVC Exports Rise as Stockpile Releases Reshape Global Supply
-
Global Oil Inventories Fall: Restocking Demand May Keep Petrochemical Costs Supported
-
BASF Zhanjiang Integrated Base Acrylate Project Mechanically Completed
-
German Chemical Industry Output Slumps to Lowest Utilization Rate Since 1991
-
AGC Sells Polycarbonate Business to Sumitomo Bakelite